Circular No. 38/2025/TT-BYT guiding the Decree No. 207/2025/NĐ-CP on assisted reproductive technology and surrogacy for humanitarian purposes issued by the Minister of Health

This is a template report on the implementation of assisted reproductive technology at a medical facility in a year. The report includes detailed information on the number of infertile couples diagnosed, the number of IUI and IVF cycles performed, success rates after applying assisted reproductive methods, as well as complications/incidents and violations during the implementation process. The purpose of this report is to provide information to the Ministry of Health regarding the activities of the medical facility related to assisted reproductive technology.

문서 번호38/2025/TT-BYT
문서 유형Circular
발행 기관Ministry of Health
서명자Nguyễn Tri Thức — Thứ trưởng
업데이트12. 06. 2026
산업Health
분야Uncategorized
발행일13. 08. 2025
발효일01. 10. 2025
효력 만료일
상태In effect
✦ 스마트 요약

This is a template report on the implementation of assisted reproductive technology at a medical facility in a year. The report includes detailed information on the number of infertile couples diagnosed, the number of IUI and IVF cycles performed, success rates after applying assisted reproductive methods, as well as complications/incidents and violations during the implementation process. The purpose of this report is to provide information to the Ministry of Health regarding the activities of the medical facility related to assisted reproductive technology.

적용 범위

Medical facilities that implement assisted reproductive technologies.

핵심 사항

  • Report on the diagnosis and treatment of infertility
  • Results of IUI and IVF methods
  • Success rates after applying assisted reproductive methods
  • Complications/incidents during the implementation of assisted reproductive technology
  • Violations during the implementation of assisted reproductive technology

🌐 이 문서의 사회적 영향

  • Provide information to the Ministry of Health about the activities of the medical facility related to assisted reproductive technology.
  • To improve the quality of healthcare services in the field of assisted reproduction.

❓ 자주 묻는 질문

To whom is this report submitted?

This report is submitted to the Ministry of Health and relevant state management agencies.

What should be noted when reporting success rates after IUI and IVF?

Success rates must be calculated based on specific data within the reporting cycle, including cases of pregnancy that did not progress or resulted in non-viable births.

If a medical facility does not perform assisted reproductive technology, is it required to submit this report?

No. The report only applies to facilities that implement assisted reproductive technologies.

전문

MINISTRY OF HEALTH
-------

SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
---------------

Number: 38/2025/TT-BYT

Hanoi, August 13, 2025

 CIRCULAR

Providing detailed regulations on certain provisions of Decree No. 207/2025/NĐ-CP dated July 15, 2025, of the Government regarding childbirth through assisted reproductive technology and conditions for surrogacy for humanitarian purposes

---------------

Decree No. Decision No. 42/2025/NĐ-CP February 27, 2025 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;

Decree No. 207/2025/NĐ-CP dated July 15, 2025, of the Government regarding childbirth through assisted reproductive technology and conditions for surrogacy for humanitarian purposes;

At the proposal of the Director of the Maternal and Child Health Department;

The Minister of Health issues this Circular providing detailed regulations on certain provisions of Decree No. 207/2025/NĐ-CP dated July 15, 2025, of the Government regarding childbirth through assisted reproductive technology and conditions for surrogacy for humanitarian purposes.

PART I

GENERAL PROVISIONS

Article 1. Scope of Regulation

This Circular stipulates health standards for sperm, egg, and embryo recipients; procedures for transferring sperm, eggs, and embryos between storage facilities; a minimum list of techniques to be performed in medical examinations and treatments at facilities conducting in vitro fertilization; statistical reporting, data management, and information sharing on reproductive assistance.

Chapter II

HEALTH STANDARDS FOR SPERM, EGG, AND EMBRYO RECIPIENTS; PROCEDURES FOR TRANSFERRING SPERM, EGGS, AND EMBRYOS BETWEEN STORAGE FACILITIES; MINIMUM LIST OF TECHNIQUES TO BE PERFORMED IN MEDICAL EXAMINATIONS AND TREATMENTS AT FACILITIES CONDUCTING IN VITRO FERTILIZATION

Article 2. Health Standards for Sperm, Egg, and Embryo Recipients

1. A recipient of sperm, eggs, or embryos must not be suffering from:

a) Any genital organ diseases or abnormalities that render them incapable of pregnancy;

b) Diseases that may endanger the life of the woman during pregnancy;

c) Mental illnesses or other conditions that prevent them from understanding or controlling their actions.

2. Individuals with acute diseases must postpone embryo transfer until their condition stabilizes after treatment.

3. The head of the facility conducting in vitro fertilization or the person authorized legally shall be responsible for organizing and implementing examinations, consultations, and conclusions on whether the individual meets the health criteria for receiving sperm, eggs, or embryos as stipulated in Clauses 1 and 2 of this Article.

Article 3. Regulations on Procedures for Transferring Sperm, Eggs, and Embryos Between Storage Facilities

1. In cases where the donor or recipient of sperm, eggs, or embryos (hereinafter referred to as "samples") wishes to transfer samples from one storage facility to another:

a) The current storage facility shall advise the donor or recipient about transport regulations, potential risks during transport, and provide written consent for sample transfer;

b) The receiving facility shall be responsible for considering the donor's or recipient's wishes and deciding whether to accept transferred samples from another storage facility. Transfer can only occur with written consent from the receiving facility;

c) Transport of samples must be carried out by healthcare staff from the receiving or donating facility, with the participation of the donor or recipient or their legal representative. If the donor or recipient or their legal representative does not participate, they must authorize the receiving or donating facility to carry out the transport;

d) Transportation costs shall be borne by the donor or recipient;

đ) During transportation, samples must be stored in specialized cryopreservation equipment sealed by the donating facility;

e) Samples must be handed over between two storage facilities along with the following documents:

- A summary of the medical record or storage file certified by the donating facility, including full information: name and ID card number or personal identification number of the donor or recipient, or passport (if foreign); quantity and quality of samples; storage method, date of storage; summary of treatment process;

- For donated samples: the storage file does not need to include personal information of the donor but must have a sample code issued by the donating facility;

- For embryo transfers: a valid copy of the marriage certificate at the time of embryo creation if it is a married couple, or a confirmation of marital status if it is a single woman;

- A transfer record of sperm, eggs, or embryos (two original copies) according to Appendix I attached to this Circular;

g) The receiving facility shall be responsible for checking the seal and accompanying documents before signing the transfer record and returning one original copy to the donating party;

2. In cases where the storage facility lacks the necessary conditions to continue storing samples:

a) The current storage facility must contact another permitted storage facility to negotiate sample transfer and inform the donor or recipient. Transfer can only occur with the consent of the donating facility, receiving facility, and donor or recipient. In urgent situations, both facilities must agree beforehand and then notify the donor or recipient;

b) Sample transport must be carried out by staff from the donating or receiving facility;

c) Transportation costs shall be borne by the donating facility;

d) During transportation, samples must be stored in specialized cryopreservation equipment sealed by the donating facility;

đ) Samples must be handed over between two storage facilities along with the following documents:

- A list of donors or recipients being transferred, fully detailing: name and ID card number or valid personal identification with personal identification number of the donor or recipient, or passport (if foreign);

- Full medical records or storage files of all cases being transported;

- A transfer record of sperm, eggs, or embryos (two original copies) according to Appendix I attached to this Circular;

e) The receiving facility shall be responsible for checking the seal and accompanying documents before signing the transfer record and returning one original copy to the donating party;

g) The donating facility shall be responsible for notifying the donor in writing about the sample transport; the receiving facility shall be responsible for continuing to store and preserve the received samples through a contract with the donor in accordance with civil law regulations.

Article 4. Minimum list of techniques for diagnosis and treatment that facilities performing in vitro fertilization must implement

Attached to this Circular is the "Minimum List of Techniques for Diagnosis and Treatment that Facilities Performing In Vitro Fertilization Must Implement" at Appendix II and Appendix III.

Chapter III

REPORTING STATISTICS, MANAGING DATA AND SHARING INFORMATION ON ASSISTED REPRODUCTION

Article 5. Reporting Statistics

Annually on January 20, facilities authorized to perform in vitro fertilization and altruistic surrogacy techniques shall be responsible for submitting reports on the implementation of assisted reproduction techniques at their facilities to the Ministry of Health, while simultaneously sending them to the directly managing state administrative agencies according to the model set forth in Appendix IV attached to this Circular.

Article 6. Managing Data and Sharing Information on Assisted Reproduction

1. Information regarding sperm donation, egg donation, embryo donation; storage of donated sperm, eggs, embryos must be encoded and shared in accordance with the provisions of Clause 2 of this Article, ensuring the confidentiality of information of donors and recipients of sperm, eggs, embryos.

2. Information required to be shared with the common database on assisted reproduction includes:

a) The most recent citizen identification card number or personal identification number or passport number (if foreign nationals) of the donor, recipient of sperm, eggs, embryos, altruistic surrogate mother, and the couple seeking altruistic surrogacy;

b) Date, month, year of donation of sperm, eggs, embryos; facility storing donated sperm, eggs, embryos;

c) Date, month, year of embryo transfer in cases of surrogacy, facility performing surrogacy technique.

3. Responsibilities of relevant agencies in managing the common database on assisted reproduction:

a) The Maternal and Child Health Department acts as the focal point, coordinating with related units to manage, operate, and utilize the common database on assisted reproduction; developing the Ministry of Health's regulations on managing, operating, and utilizing the common database on assisted reproduction to serve management, operational activities, professional work, and state administration; inspecting and supervising compliance;

b) The Science, Technology and Training Department coordinates in developing the Ministry of Health's regulations on managing, operating, and utilizing the common database on assisted reproduction; participating in inspecting and supervising compliance;

c) The National Health Information Center takes the lead, coordinating with the Maternal and Child Health Department and related units to build the common database on assisted reproduction; being responsible for technical infrastructure, information security, and operation of the database;

d) Medical establishments authorized to perform in vitro fertilization and altruistic surrogacy techniques are responsible for connecting and sharing information with the common database on assisted reproduction in accordance with the Ministry of Health's regulations.

Chapter IV

IMPLEMENTING PROVISIONS

Article 7. Effective Date

1. This Circular takes effect from October 1, 2025.

2. Abolish Chapter I, Chapter II, Chapter V, and Chapter VI of Circular No. 57/2015/TT-BYT dated December 30, 2015 issued by the Minister of Health detailing certain provisions of Decree No. 10/2015/NĐ-CP dated January 28, 2015 of the Government on assisted reproductive technology and conditions for altruistic surrogacy.

3. In cases where the referenced documents in this Circular are amended, supplemented, or replaced, they shall be applied according to the new documents.

Article 8. Responsibility for Implementation

Director of the Maternal and Child Health Department; Director of the Department of Medical Examination and Treatment Management; Heads of units under and affiliated with the Ministry of Health; Directors of Health Departments of provinces and centrally-administered cities; relevant agencies, organizations, and individuals are responsible for implementing this Circular.


Place of Receipt:
- National Assembly Cultural and Social Committee;
- Office of the Government (Department of Legal Affairs, Official Gazette, Government Portal);
- Minister (for reporting);
- Deputy Ministers of Health
- Ministry of Justice (Department of Legal Drafting and Management of Legal Documents);
- Ministries, agencies equivalent to ministries, and government agencies;
- People's Committees of provinces and centrally governed cities;
- Units under the Ministry of Health;
- Health Departments of provinces and centrally governed cities;
- Ministry of Health’s Official Website, Maternal and Child Health Department’s Official Website;
- To be filed: VT, BMTE, PC.

DEPUTY MINISTER
DEPUTY MINISTER

(Signed)

Nguyen Tri Thuc

 

ANNEX I

MODEL OF RECORD FOR TRANSFER OF SPERM, EGGS, EMBRYOS
(Attached to Circular No. 38/2025/TT-BYT dated August 13, 2025 issued by the Minister of Health)

SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
---------------

RECORD OF TRANSFER OF SPERM, EGGS, EMBRYOS

Today, at ... hours ... minutes, on ... day ... month ... year

At: ...

Donating Facility: ...

Represented by Mr./Ms. ...

Citizen Identification Number: ... Phone Number: ...

Transfer Process:

- Sperm: Number of vials ...

- Eggs/Embryos: Number of frozen strands: ... Number of eggs/embryos ... 1..…………

(Unable to accurately determine quantity and quality of samples at time of transfer)

To:

Receiving Facility: ………………………………………………………………………

Represented by Mr./Ms. ...

Citizen Identification Number: ... Phone Number: ...

Information about transferred samples:

Serial number

Name of sample sender/donor

Code Number2

Citizen ID number (or personal identification number)

Type and quantity of samples4

1

 

 

 

 

2

 

 

 

 

 

 

 

 

Total number of sample senders/donors: ... people.

Accompanying documents include:

…………………………………………………………………………………………………….

…………………………………………………………………………………………………….

…………………………………………………………………………………………………….

…………………………………………………………………………………………………….

This record is made in two original copies with equal legal force, each party retains one original copy./.

 

 

..., day ... month ... year ...

SAMPLE SENDER/
DONOR5

(Signature, full name)

 

 

HEALTH CARE STAFF
HANDING OVER SAMPLES

(Signature, full name)

HEALTH CARE STAFF
RECEIVING SAMPLES

(Signature, full name)

REPRESENTATIVE OF THE DONATING FACILITY
(Signature, full name)

REPRESENTATIVE OF THE RECEIVING FACILITY
(Signature, full name)

       

 

__________________________

1 Clearly indicate the type and quantity of samples transferred.

2 Indicate the code if the transferred sample is a donation. If it is not a donation, leave blank.

3 Indicate passport number if the person is a foreign national. If the sample transferred is a donation, leave blank.

4 In case of transferring samples from two or more senders, clearly indicate the type and quantity of samples from each person.

5 Indicate the name of the sample sender. If the transferred sample is a donation, indicate the name of the sample recipient.

 

ANNEX II

MINIMUM LIST OF TECHNIQUES FOR DIAGNOSIS AND TREATMENT THAT FACILITIES PERFORMING IN VITRO FERTILIZATION MUST IMPLEMENT UNTIL JUNE 30, 2026
(Attached to Circular No. 38/2025/TT-BYT dated August 13, 2025 issued by the Minister of Health)

Serial number

Name and corresponding technique code in Appendix 01 of Circular No. 23/2024/TT-BYT dated October 18, 2024

Serial number

Technique Code

Technique Name

1

13579

BS_13.254

Anesthesia during egg retrieval procedure

2

13529

13.204

Egg retrieval

3

13530

13.205

Embryo transfer

4

13545

13.220

Intrauterine insemination (IUI)

5

13583

BS_13.258

Reduced anesthesia for multiple pregnancies

6

13576

BS_13.251

Embryo reduction (Multiple pregnancy reduction)

7

13537

13.212

Testicular sperm aspiration, epididymal sperm aspiration

8

13591

BS_13.266

Sperm injection into oocytes (In Vitro Fertilization - IVF)

9

13539

13.214

Intracytoplasmic sperm injection (ICSI)

10

13532

13.207

Embryo culture

11

13528

13.203

Embryo hatching support

12

13533

13.208

Embryo, oocyte cryopreservation

13

13534

13.209

Embryo, oocyte thawing

14

13535

13.210

Sperm cryopreservation

15

13536

13.211

Sperm thawing

16

13544

13.219

Sperm washing

17

17482, 17488

BS_23.276 BS_23.282

Semen analysis by manual method

18

17218

23.12

Anti-Mullerian hormone (AMH) quantification [Blood] 2

19

17230

23.24

Beta-human chorionic gonadotropin (bhCG) quantification [Blood] 2

20

17267

23.61

Estradiol quantification [Blood] 2

21

17271

23.65

Quantification of FSH (Follicular Stimulating Hormone) [Blood] 2

22

17316

23.110

Quantification of LH (Luteinizing Hormone) [Blood] 2

23

17337

23.131

Quantification of Prolactin [Blood] 2

24

17340

23.134

Quantification of Progesterone [Blood] 2

25

17357

23.151

Quantification of Testosterone [Blood] 2

26

57

1.57

Oxygen inhalation through nasal prongs

27

58

1.58

Oxygen inhalation through a mask without a reservoir bag

28

65

1.65

Ambu bag ventilation through a mask

29

160

1.160

Insertion of a urinary catheter for bladder drainage

30

165

1.165

Bladder washout to remove clots

31

158

1.158

Basic cardiopulmonary resuscitation

 

___________________________

1 In case Circular No. 23/2024/TT-BYT dated October 18, 2024 amends, supplements, or replaces the list of techniques in medical examination and treatment, such provisions shall be applied according to the new document.

2 Techniques numbered from 17 to 24 may be provided by another entity that has been authorized to perform these techniques through a cooperation contract in accordance with the law.

 

ANNEX III

MINIMUM LIST OF TECHNIQUES IN MEDICAL EXAMINATION AND TREATMENT THAT FACILITIES PERFORMING IN-VITRO FERTILIZATION MUST IMPLEMENT FROM JULY 1, 2026
(Attached to Circular No. 38/2025/TT-BYT dated August 13, 2025 issued by the Minister of Health)

Serial number

Name and corresponding technique code in Appendix 01 of Circular No. 23/2024/TT-BYT dated October 18, 2024

Serial number

Technique Code

Technique Name

1

4299

13.204

Oocyte retrieval technique in IVF

2

4301

13.205

Embryo transfer into the uterus

3

4315

13.220

Intrauterine insemination (IUI)

4

4313

13.218

Embryo or fetal reduction

5

4316

 

Classical method of sperm fertilization with oocytes

6

4311

13.214

Intracytoplasmic sperm injection into oocytes

7

4303

13.207

Embryo culture

8

4298

13.203

Assisted hatching of embryos

9

4304

13.208

Embryo cryopreservation

10

4305

13.208

Oocyte cryopreservation

11

4306

13.209

Embryo thawing

12

4307

13.209

Oocyte thawing

13

4309

13.210

Sperm cryopreservation

14

4310

13.211

Sperm thawing

15

4314

13.219

Sperm washing

16

3953

 

PESA surgery: transcutaneous sperm aspiration from the epididymis

17

7560

 

Semen analysis by manual method

18

7606

23.24

β-hCG (beta-human chorionic gonadotropin): IU/L: serum/plasma: Quantification (immunoassay)2

19

7609

23.65

FSH (follicle-stimulating hormone): IU/L: serum/plasma: Quantification (immunoassay) 2

20

7611

23.110

LH (luteinizing hormone): IU/L: serum/plasma: Quantification (immunoassay) 2

21

7613

23.131

Prolactin: μg/L: serum/plasma: Quantification (immunoassay) 2

22

7656

 

Quantification of Free Testosterone (Free Testosterone) 2

23

7663

23.61

E2 (estradiol): pmol/L: serum/plasma: Quantification (immunoassay) 2

24

7665

23.134

Progesterone: nmol/L: serum/plasma: Quantification (immunoassay) 2

25

7691

 

Fructose: μmol/liter ejaculation: semen: Quantification (photometric assay) 2

26

7753

23.12

AMH (anti-Müllerian hormone): pmol/L: serum/plasma: Quantification (immunoassay) 2

27

7835

23.151

Testosterone: nmol/L: serum/plasma: Quantification (immunoassay) 2

28

6067

 

Intravenous anesthesia

29

6080

 

Local anesthesia

30

6268

1.158, 3.113

Basic cardiopulmonary resuscitation

31

6332

 

Oxygen inhalation technique through a mask with a reservoir bag

32

6333

 

Oxygen inhalation technique through a T-piece mask

33

6334

 

Oxygen inhalation technique through a mask without a reservoir bag

34

6368

 

Patient monitoring technique after intervention

35

1743

2.233

Bladder washout

 

__________________________

1 In case Circular No. 23/2024/TT-BYT dated October 18, 2024 amends, supplements, or replaces the list of techniques in medical examination and treatment, such provisions shall be applied according to the new document.

2 Techniques numbered from 18 to 27 may be provided by another entity that has been authorized to perform these techniques through a cooperation contract in accordance with the law.

 

ANNEX IV

SAMPLE REPORT ON THE IMPLEMENTATION OF ASSISTED REPRODUCTIVE TECHNOLOGIES
(Attached to Circular No. 38/2025/TT-BYT dated August 13, 2025 issued by the Minister of Health)

MEDICAL EXAMINATION AND TREATMENT FACILITY,
TREATMENT FACILITY

-------

SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
---------------

No.: ……BC-……

………, day ….. month ….. year 20….

Medical Examination and Treatment Facility Code: …

 

 

REPORT

SITUATION OF THE IMPLEMENTATION OF ASSISTED REPRODUCTIVE TECHNOLOGIES

Reporting period: From January 1 to December 31, …

Respectfully submitted to: Ministry of Health

Medical Examination and Treatment Facility … reports on the implementation of assisted reproductive technologies in … as follows:

1. Results:

Serial number

Content

Number/Ratio

Remarks

1

Number of couples diagnosed with infertility

 

 

INTRAUTERINE INSEMINATION (IUI)

2

Number of couples undergoing IUI

 

 

3

Number of single women undergoing IUI

 

 

4

Number of IUI cycles performed:

 

 

- Number of IUI cycles for couples

 

 

- Number of IUI cycles using donor sperm

 

 

5

Ratio of pregnancies progressing after IUI

 

 

IN-VITRO FERTILIZATION (IVF); SPERM, OVUM, EMBRYO DONATION AND SURROGACY FOR HUMANITARIAN PURPOSES

6

Number of IVF cycles

 

 

7

Number of couples undergoing IVF

 

 

8

Number of single women undergoing IVF

 

 

9

Number of live births resulting from IVF

 

 

10

Number of sperm donors

 

 

11

Number of ovum retrieval cycles:

 

 

11.1

- In vitro fertilization

 

 

11.2

- Number of ovum retrieval cycles from donors

 

 

11.3

- Number of women storing eggs for medical and social reasons

 

 

12

Number of embryo transfers:

 

 

12.1

- Fresh embryo transfer

 

 

12.2

- Frozen embryo transfer

 

 

13

Average number of embryos transferred per cycle

 

 

14

Number of egg donors

 

 

15

Number of sperm donors

 

 

16

Number of recipients of donated embryos

 

 

17

Number of couples undergoing surrogacy for humanitarian purposes

 

 

18

Number of live births resulting from surrogacy for humanitarian purposes

 

 

19

Ratios:

 

 

19.1

Clinical pregnancy rate after IVF

 

 

19.2

Progressing pregnancy rate after IVF

 

 

19.3

Live birth rate after IVF

 

 

19.4

Multiple pregnancy rate

 

 

OTHER TECHNIQUES

20

Number of cases of sperm retrieval by surgical or procedural methods

 

 

21

Number of cases of embryo reduction

 

 

22

Number of cases of preimplantation genetic testing (PGT)

 

 

23

Number of cases of embryo transfer following preimplantation genetic testing (PGT)

 

 

COMPLICATIONS/INCIDENTS

24

Number of cases requiring hospitalization for internal or surgical treatment:

 

 

24.1

- Severe ovarian hyperstimulation syndrome

 

 

24.2

- Ovarian torsion

 

 

24.3

- Hemorrhage after ovum retrieval

 

 

24.4

- Hemorrhage after sperm retrieval surgery

 

 

24.5

- Adverse reactions to fertility drugs

 

 

25

Number of cases of gamete or embryo misidentification:

 

 

25.1

- Risk of using the wrong embryo or gamete but identified before use

 

 

25.2

- Use of the wrong embryo or gamete (regardless of pregnancy outcome)

 

 

26

Other complications (specify)

 

 

2. Violations:

- Detected: …

- Handling: …

- Others: …

3. Recommendations and Suggestions:

…………………………………………………………………………………………

…………………………………………………………………………………………

…………………………………………………………………………………………

 


Place of Receipt:
- As above;
- Competent authority;
- Directly managing health administration agency;
- To be kept: medical examination and treatment facility.

HEAD OF THE AUTHORITY
(Signature, full name, stamp)

 

GUIDELINES FOR REPORTING

The figures recorded for each reporting period, except those specified in items 5 and 19 below, are as follows:

5. Pregnancy progression rate after IUI

19.1. Clinical pregnancy rate after IVF

19.2. Pregnancy progression rate after IVF

19.3. Live birth rate after IVF

19.4. Multiple pregnancy rate

 

원본 문서(PDF)

새 탭에서 PDF 열기 ↗